BLOOMFIELD HILLS, Mich., Oct. 16, 2017 -- O2 Investment Partners (“O2”) recently closed its Oxygen Fund, exceeding its $100 million fund target. The Oxygen Fund will continue O2’s successful track record of investing in the lower middle market.
Launched in Q3 2016, the Oxygen Fund has made control investments in two platforms: Clio Holdings, a national roll-up involving six acquisitions in the stone and engineered countertop segment, serving residential, commercial and remodeling markets (www.clioholdings.com); and MHC Software, a leader in document management and electronic transaction processing software (www.mhcsoftwareinc.com). Todd Fink, Managing Partner, commented, “After deploying over $80 million of equity through an informal structure led by our anchor family office partners, converting to a committed fund structure through the Oxygen Fund is the next logical step in our evolution. The Oxygen Fund will enhance our ability to quickly execute transactions and attract and retain outstanding talent. With a similar and expanded investor base, this fund preserves our 'family office' culture and positions O2 Investment Partners for continued success in the lower middle market.”
About O2 Investment Partners:
O2 Investment Partners is a Midwestern based private equity firm that seeks to acquire a majority interest in lower middle market manufacturing, niche distribution, and select service and technology businesses. The firm invests in businesses with earnings growth potential and a clear path to the creation of shareholder value.
O2 invests with a view toward partnering with management to build and grow the business and take it to its next stage of development. This requires not only a clear vision and strategic plan to create shareholder value, but a close partnership and alignment of interest with management.
Additional information is available at www.o2investment.com
CONTACT: Todd Fink, O2 Investment Partners ([email protected])


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



